Jay S. Duker, M.D. has served as a member of our Board since January 2015 and as Chair since February 2020. Dr. Duker is currently the Chief Operating Officer of EyePoint Pharmaceuticals, Inc. Prior to joining EyePoint, Dr. Duker was the Director of the New England Eye Center from 2001 to 2021. He also served as Chair of the Department of Ophthalmology at Tufts Medical Center and the Tufts University School of Medicine from 2003 to 2021. He is a Professor of Ophthalmology at the Tufts University School of Medicine. He has published more than 300 journal articles, with his major research interests including retinal imaging, in particular optical coherence tomography (OCT), retinal vascular diseases, and drug delivery to the posterior segment. His book, Yanoff and Duker’s Ophthalmology, is one of the bestselling ophthalmic texts over the past three decades, now in its fifth edition. Dr. Duker is the co-founder of three companies, including Hemera Biosciences, a biotech start-up whose focus is a gene therapy-based treatment for age-related macular degeneration which was acquired by Janssen in 2020. Dr. Duker received an A.B. from Harvard University and a M.D. from the Jefferson Medical College at Thomas Jefferson University.

Chair of the Board
Chair of the Nominating and Governance Committee
Chair of the Compensation Committee
Member of the Science Committee